157 related articles for article (PubMed ID: 24769274)
1. A useful multi-analyte blood test for cerebrotendinous xanthomatosis.
DeBarber AE; Luo J; Giugliani R; Souza CF; Chiang JP; Merkens LS; Pappu AS; Steiner RD
Clin Biochem; 2014 Jun; 47(9):860-3. PubMed ID: 24769274
[TBL] [Abstract][Full Text] [Related]
2. A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns.
DeBarber AE; Luo J; Star-Weinstock M; Purkayastha S; Geraghty MT; Chiang JP; Merkens LS; Pappu AS; Steiner RD
J Lipid Res; 2014 Jan; 55(1):146-54. PubMed ID: 24186955
[TBL] [Abstract][Full Text] [Related]
3. ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis.
DeBarber AE; Connor WE; Pappu AS; Merkens LS; Steiner RD
Clin Chim Acta; 2010 Jan; 411(1-2):43-8. PubMed ID: 19808031
[TBL] [Abstract][Full Text] [Related]
4. Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method.
Bleyle L; Huidekoper HH; Vaz FM; Singh R; Steiner RD; DeBarber AE
Mol Genet Metab Rep; 2016 Jun; 7():11-5. PubMed ID: 27331003
[TBL] [Abstract][Full Text] [Related]
5. Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis.
DeBarber AE; Sandlers Y; Pappu AS; Merkens LS; Duell PB; Lear SR; Erickson SK; Steiner RD
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(17-18):1384-92. PubMed ID: 21168372
[TBL] [Abstract][Full Text] [Related]
6. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
[TBL] [Abstract][Full Text] [Related]
7. Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.
Pajares S; Arias A; García-Villoria J; Macías-Vidal J; Ros E; de las Heras J; Girós M; Coll MJ; Ribes A
J Lipid Res; 2015 Oct; 56(10):1926-35. PubMed ID: 26239048
[TBL] [Abstract][Full Text] [Related]
8. Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings.
Guenzel AJ; DeBarber A; Raymond K; Dhamija R
JIMD Rep; 2021 May; 59(1):3-9. PubMed ID: 33977023
[TBL] [Abstract][Full Text] [Related]
9. Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spots.
Hong X; Daiker J; Sadilek M; DeBarber AE; Chiang J; Duan J; Bootsma AH; Huidekoper HH; Vaz FM; Gelb MH
Genet Med; 2020 Oct; 22(10):1606-1612. PubMed ID: 32523054
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment.
DeBarber AE; Kalfon L; Fedida A; Fleisher Sheffer V; Ben Haroush S; Chasnyk N; Shuster Biton E; Mandel H; Jeffries K; Shinwell ES; Falik-Zaccai TC
J Lipid Res; 2018 Nov; 59(11):2214-2222. PubMed ID: 30135217
[TBL] [Abstract][Full Text] [Related]
11. Clinical, biochemical, and molecular insights into Cerebrotendinous Xanthomatosis: A nationwide study of 100 Turkish individuals.
Zubarioglu T; Kıykım E; Köse E; Eminoğlu FT; Teke Kısa P; Balcı MC; Özer I; İnci A; Çilesiz K; Canda E; Yazıcı H; Öztürk-Hişmi B; Bulut FD; Dorum S; Akgun A; Yalçın-Çakmaklı G; Kılıç-Yıldırım G; Soyuçen E; Akçalı A; Güneş D; Durmuş A; Gündüz A; Kasapkara ÇS; Göksoy E; Akar HT; Ersoy M; Erdöl Ş; Yıldız Y; Hanağası HA; Arslan N; Aktuğlu-Zeybek Ç
Mol Genet Metab; 2024 Jun; 142(2):108493. PubMed ID: 38772327
[TBL] [Abstract][Full Text] [Related]
12. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
13. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
[TBL] [Abstract][Full Text] [Related]
14. A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.
Takahashi M; Okazaki H; Tada H; Ishibashi S
J Clin Lipidol; 2023; 17(6):834-838. PubMed ID: 37777472
[TBL] [Abstract][Full Text] [Related]
15. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis.
Höflinger P; Hauser S; Yutuc E; Hengel H; Griffiths L; Radelfahr F; Howell OW; Wang Y; Connor SL; Duell PB; DeBarber AE; Martus P; Lütjohann D; Griffiths WJ; Schöls L
J Lipid Res; 2021; 62():100078. PubMed ID: 33891937
[TBL] [Abstract][Full Text] [Related]
18. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
Batta AK; Salen G; Tint GS
Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
[TBL] [Abstract][Full Text] [Related]
19. Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataracts.
Fernández-Eulate G; Martin GC; Dureau P; Speeg-Spatz C; Brassier A; Gillard P; Bremond-Gignac D; Thouvenin D; Pagan C; Lamari F; Nadjar Y
Orphanet J Rare Dis; 2022 Dec; 17(1):434. PubMed ID: 36514115
[TBL] [Abstract][Full Text] [Related]
20. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
J Clin Lipidol; 2024 Mar; ():. PubMed ID: 38637260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
